Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I

Clinical trial NCT03882840 · RECRUITING

Trial details

NCT number: NCT03882840
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anti-cancer Cell Immunotherapy T Cell and NK Cell

Start date: 2019-01-01
Primary completion: 2028-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.